Search Results

​
search
MDA - New FDA Treatment Approved for SMA
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
February 12, 2025 12:48 ET | Muscular Dystrophy Association
New York, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today celebrates the decision by the US Food and Drug Administration (FDA) to grant approval of a risdiplam...